Enterococcus faecalis is an early coloniser of the human infant gut and contributes to the development 17 of intestinal immunity. To better understand the functional capacity of E. faecalis we constructed a 18 broad host range RP4 mobilisable vector, pEHR513112, that confers chloramphenicol resistance and 19 used a metaparental mating approach to isolate E. faecalis AHG0090 from a faecal sample collected 20 from a healthy human infant. We demonstrated that E. faecalis AHG0090 is genetically tractable and 21 could be manipulated using traditional molecular microbiology approaches. E. faecalis AHG0090 was 22 comparable to the gold-standard anti-inflammatory bacterium Faecalibacterium prausnitzii A2-165 in 23 its ability to suppress cytokine mediated NF-B activation in human gut derived LS174T goblet cell-24 like and Caco-2 enterocyte-like cell lines. E. faecalis AHG0090 and F. prausnitzii A2-165 produced 25 secreted low molecular weight NF-B suppressive peptidic bioactives. Both bioactives were sensitive 26 to heat and proteinase K treatments although the E. faecalis AHG0090 bioactive was more resilient to 27 both forms of treatment. As expected, E. faecalis AHG0090 suppressed IL-1 induced NF-B-p65 28 subunit nuclear translocation and expression of the NF-B regulated genes IL-6, IL-8 and CXCL-10. 29
Introduction 32
The human gut represents the largest mucosal surface area and is the largest immune organ of the body 33 (Chassaing et al., 2014). Full-term infants are born with a competent but immature immune system 34 that must respond appropriately to the inevitable exposure to microbes that occurs following birth. The non-pathogenic gut strains, and the identity of the bioactives that underpin them, remains largely 48 unknown. 49
Taken together, we hypothesised the infant gut microbiota would be a fertile source of 50 immunomodulatory bioactive factors with potential prophylactic or therapeutic applications. We 51 previously reported a method termed metaparental mating that enables the rapid and directed isolation 52 of genetically tractable human gut bacteria (Ó Cuív et al., 2015) . In this study, we describe the isolation 53 of E. faecalis AHG0090 and demonstrate that similar to Faecalibacterium prausnitzii A2-165 54 (Quevrain et al., 2016; Breyner et al., 2017) , it produces a potent peptidic bioactive that suppresses NF-55
B activation. Finally, we demonstrate that E. faecalis AHG0090 can be manipulated using traditional 56 molecular techniques providing new opportunities to dissect the functional capacity of the human gut 57 microbiota. 58
Vector construction and manipulation. To construct pEHR513111, catP was PCR amplified from 83 pJIR1456 (Lyras and Rood, 1998) with primers (Pf 5 GAT CGT TTA AAC AGT GGG CAA GTT  84  GAA AAA TTC AC; Pr 5 GAT CCC TGC AGG TTA GGG TAA CAA AAA ACA CCG TAT TTC  85 TAC) that introduced unique PmeI and SbfI restriction sites. The digested catP was then cloned into 86 pEHR512111, replacing erm, and generating pEHR513111. OD600nm of the cultures was monitored longitudinally and 5 ml of cultures was harvested from each 156 broth culture at early exponential, mid-exponential, early stationary and late stationary phase of growth. 157
At each collection, 1.5 ml of each culture was centrifuged at 16,000 x g for 5 minutes and 0.5 ml of the 158 cell-free supernatant fraction was transferred to fresh tubes and stored at -30 o C as single-use aliquots. 159
For the immunomodulatory assays, 96-well microtiter plates were seeded with 20,000 LS174T-NF-160 kBluc or Caco-2-NF-kBluc reporter cells per well as previously described (Ó Cuív et al., 2017). The 161 ability of the cell free bacterial supernatants to suppress NF-B activation in LS174T-NF-kBluc was 162 assessed by adding supernatant (10% v/v in complete DMEM medium) to the cells and incubating for 163 30 minutes at 37°C. The LS174T and Caco-2 reporter cell lines were then stimulated with TNF 164 (25ng.ml -1 ) or IL-1β (50 ng.ml -1 ) respectively in the presence of 10% v/v supernatant for 4 hours before 165
assessing luciferase activity. The ability of the supernatants to suppress activation was compared to 166 the NF-B inhibitor indole-3-carbinol (I3C, 5 M). NF-κB driven luciferase expression was assessed 167
using the Pierce TM Firefly Luc One-Step Glow Assay Kit (ThermoFisher Scientific) according to the 168 manufacturer's instructions. The cytotoxicity of the supernatants was assessed using Cell Proliferation 169
Reagent WST-1 (Sigma Aldirch) according to the manufacturer's instructions. 170
Nuclear translocation immunofluorescence assays. Glass coverslips in a 12 well-plate were seeded 171 with 20,000 Caco-2 cells per well and cultured overnight. Cell-free culture supernatants harvested 172 from mid-exponential phase cultures were added (10% v/v) to the Caco-2 cells and incubated for 30 173 min, and then stimulated with IL-1 (25ng.ml -1 ) for 1 hour. Cells were also treated with BHI medium 174 and I3C alone. The cells were then processed and analysed as previously described (Ó Cuív et Figure 1A ). 192
Following metaparental mating we recovered 14 transconjugants and assessed the clonality of 12 193
isolates by plasmid profiling. All 12 isolates carried a plasmid of comparable molecular weight to 194 pEHR513112 in addition to at least two other plasmids (~1.4 kb closed covalent circular form, ~3.2 kb 195 closed covalent circular form) ( Figure 1B ). However, the plasmid DNA profiles of all 12 isolates were 196
virtually identical suggesting they were clonal. Based on these observations we chose one 197 transconjugant for further analysis and produced 1473 bp of 16S rRNA sequence. Based on this 198 sequence we determined the isolate was affiliated with the Enterococcus faecalis taxon, and hereafter 199 it is referred to as E. faecalis AHG0090. 200 E. faecalis AHG0090 is genetically tractable. We examined whether E. faecalis AHG0090 can be 201 genetically manipulated using traditional techniques in molecular microbiology. E. faecalis AHG0090 202 was grown in BHI broth supplemented with acridine orange to cure pEHR513112. The addition of 203 acridine orange up to 8 g.ml -1 did not affect growth however all the colonies recovered on BHI 204 medium were sensitive to chloramphenicol suggesting they had lost pEHR513112. Plasmid DNA 205 prepared from E. faecalis AHG0090 recovered by metaparental mating carried a plasmid with the same 206 molecular weight as pEHR513112 however, this plasmid was absent from naïve E. faecalis AHG0090 207 ( Figure 2A ). We next confirmed that naïve E. faecalis AHG0090 was genetically tractable by using it 208
as the recipient in a biparental mating with E. coli ST18 carrying pEHR513112. Using our standard 209
biparental mating protocol we recovered transconjugants and achieved a conjugation efficiency of 3.83 210
x 10 -7 transconjugants per recipient. As expected, the biparental mating derived transconjugant carried 211 the pEHR513112 plasmid band (Figure 2A ) and plasmid recovery experiments from the metaparental 212 mating and re-transformed isolates confirmed the plasmids were stably maintained ( Figure 2B ). 213
Consistent with these observations the re-transformed but not naïve strain was fluorescent ( Figure 2C ). 214
Notably, the endogenous plasmids were unaffected by the acridine orange treatment suggesting that 215 they are stably maintained. 216
E. faecalis AHG0090 produces an NF-B suppressive peptidic bioactive.
Given the 217 immunomodulatory activity previously ascribed to E. faecalis isolates we examined the ability of E. 218 faecalis AHG0090 to suppress cytokine mediated epithelial NF-B activation using our LS174T and 219
Caco-2 reporter cell lines. E. faecalis AHG0090 was grown in BHI medium and achieved a specific 220 growth rate of 1.630.14 h -1 (Growth rateSD) during exponential growth phase and a maximum 221 recorded yield of 3.740.07 (OD600SD) following 8 hours of growth ( Figure 3A) . Cell free 222 supernatants were harvested from early exponential, mid-exponential, early stationary and late 223 stationary phase cultures as the closely related bacterium Lactobacillus plantarum produces 224
immunomodulins that inhibit IFN production in a growth phase dependent manner (Zvanych et al., 225 2014) . Culture supernatant harvested from all four-time points suppressed NF-B activation in both 226 cell lines although the extent of suppression was greatest with supernatants harvested from mid-227 exponential phase onward ( Figure 3B ). 228
We compared the NF-B suppressive capacity of E. faecalis AHG0090 to the model anti-inflammatory 229 gut bacterium F. prausnitzii A2-165 and determined that both strains suppressed NF-B activation to 230 a similar extent in the LS174T and Caco-2 reporter cell lines ( Figure 4A ). Critically, the E. faecalis 231 AHG0090 and F. prausnitzii A2-165 cell free supernatants did not exert cytotoxic effects. The E. 232 faecalis AHG0090 culture supernatant was fractionated by passing it through a 3 kDa molecular weight 233 cut-off filter and the NF-B suppressive activity of the flow-through but not the retentate was similar 234
to that of the unfractionated culture supernatant ( Figure 4A, p>0.05) . We next assessed the impact of 235
heat and proteinase K treatments on the F. prausnitzii A2-165 and E. faecalis AHG0090 NF-B 236 suppressive bioactives. The activity of the F. prausnitzii A2-165 <3 kDa culture supernatant fraction 237
was not significantly different to the RCM control following heat (57 and 97C) or proteinase K 238 treatment ( Figure 4B, p>0.05) , consistent with the NF-B suppressive capacity of this bacterium being 239 mediated by Mam derived peptides (Quevrain et al., 2016). The E. faecalis AHG0090 <3 kDa culture 240 supernatant fraction displayed similar characteristics but still retained activity following treatment at 241 57C for 30 min or proteinase K digestion for 1 hour when compared to the BHI control ( Figure 4B,  242 p<0.05). This activity was lost at higher temperatures or following longer heat treatment, and following 243 extended proteinase K treatment ( Figure 4B, p>0.05) . Taken together, these data suggest E. faecalis 244 AHG0090 secretes a low molecular weight NF-B suppressive peptidic bioactive with differing 245
properties to the F. prausnitzii Mam peptides. 246
E. faecalis AHG0090 inhibits NF-B-p65 subunit nuclear translocation and cytokine expression. 247
Cytokine mediate activation of the NF-B pathway results in nuclear translocation of the NF-B-p65 248 subunit. We examined the ability of culture supernatant harvested from mid-exponential phase cultures 249 of E. faecalis AHG0090 to suppress NF-p65 subunit nuclear translocation. NF-p65 subunit 250 nuclear translocation induced by IL-1 in Caco-2 cells was unaffected by treatment with BHI medium. 251
In contrast, E. faecalis AHG0090 mid-exponential phase culture supernatant treatment significantly 252 reduced nuclear translocation in a similar fashion to the pharmacological inhibitor I3C ( Figure 5A ). 253
As expected, I3C and E. faecalis AHG0090 culture supernatant suppressed expression of the NF-254
dependent genes IL-6 (p<0.05), IL-8 (p<0.01) and CXCL10 (p<0.001), as determined by qRT-PCR 255 ( Figure 5B) . 256 E. faecalis AHG0090 is adapted for gut colonisation. We sequenced the E. faecalis AHG0090 257 genome to provide insights into the factors supporting colonisation and persistence in the infant gut. 258
We produced 2,925,542 bp of DNA sequence at 107x coverage. The sequenced data was assembled 259 into 116 contigs providing a contig N50 of 144,336 bp and L50 of 8. Critically, the genome was assessed 260
by CheckM as being essentially complete (99.63%) and free from contamination. The genome has a 261 G+C content of 37.3% and is predicted to contain 2,929 protein-coding genes and 60 structural RNAs. 262
Analysis of E. faecalis phylogeny using the GTDB revealed that E. faecalis AHG0090 clusters closely 263 with three strains termed E. faecalis TX0630, TX0635 and TX0645, and distally from the E. faecalis 264 type strains (E. faecalis ATCC19433 and 29200), and other gut commensal (e.g. E. faecalis PC1.1, 62 265
and Symbioflor1) and pathogenic (E. faecalis V583) strains ( Figure 6A) . Although E. faecalis is 266 characterised by extensive horizontal gene transfer there is a high degree of synteny between E. faecalis 267 AHG0090 and the closed commensal (E. faecalis 62) and pathogenic (E. faecalis V583) strains (Figure 268 6B). 269
We identified several plasmids in the E. faecalis AHG0090 genome sequence. pAHG0090c is a 270 predicted to be 76,529 bp and is comprised of 11 contigs. It is predicted to encode 80 genes and 271 displays sequence similarity and synteny to another plasmid from E. and is predicted to encode a single protein predicted to function in plasmid replication. 286
We also identified pEHR513112 in the genome sequence. There were 4 differences between the 287 compiled pEHR513112 sequence and the vector carried by E. faecalis AHG0090. We identified a 288
G86T transversion in the cphy_3290 promoter and a C2407T transition in oriT vector modules. We 289 also identified a 1 bp deletion at the 5 (AscI) end and a separate 11 bp deletion at the 3 (PmeI) end of 290 the pMB1 module. Notably, these deletions occurred within the primer sequences used to PCR amplify 291 the pMB1 module. 292
The E. faecalis AHG0090 chromosome is predicted to encode a range of niche factors that likely 293 support colonisation and persistence in the infant gut. Many Enterococci are non-motile and the ability 294 to adhere to the host epithelium likely plays a role in preventing wash-out. least in part to early differences in gut colonisation and immune modulation. Much remains to be 319 discovered about the bacteria and bioactive factors that underpin these events, and whether they could 320 be exploited to optimise health and appropriate establishment of gut mucosal immunity. 321
In this study, we describe the isolation of a genetically tractable E. faecalis strain from infant stool and 322 demonstrate that it produces a potent NF-B suppressive bioactive. The suppressive activity of E. 323
faecalis AHG0090 was clearly apparent in early exponential phase culture supernatants and did not 324 increase significantly from mid-exponential phase onward. This suggests the bioactive is produced in 325 early growth and persists in the culture supernatant through the proceeding phases of growth. Microbial culturing is a time consuming and labour-intensive process although this provides the best 364 opportunity to link genes with function. We believe focusing culturing efforts on genetically tractable 365 strains will ultimately expedite the functional dissection of the microbiome. We previously observed 366 the pEHR plasmids are stably maintained in their recipient hosts (Ó Cuív et al., 2015) . We have now 367 demonstrated they are maintained in E. faecalis AHG0090 and that this strain can be manipulated using 368 standard molecular microbiology approaches for transformation and plasmid curing. We did identify 369 some minor differences between the compiled pEHR vector sequences and those produced from the 370 genome sequence data and we believe that these likely occurred during the vector construction process. 371 We are continuing to extend the functionalities of the pEHR vector system and we anticipate that this 372 will enable us to apply forward and/or reverse genetic approaches to functionally dissect E. faecalis 373 AHG0090 and other gut microbes. In conclusion, we demonstrated that metaparental mating can be used to isolate genetically tractable 381 bacteria from the human gut that possess potent anti-inflammatory activities. Although E. faecalis is 382 amongst the best characterised Firmicutes affiliated gut bacteria our data suggests that this taxon 383 possesses novel anti-inflammatory capacities. Several fastidious anaerobic gut bacteria have been 384 suggested as next generation probiotics for chronic gut diseases but E. faecalis may be a superior 385 candidate due to its ease of propagation. We anticipate that the genetic dissection of E. faecalis 386 AHG0090 will provide new insights into the immunomodulatory capacity of this taxon, and a deeper 387 understanding of the early life events that help establish a tolerogenic immune response. reporter cell lines were measured by the luciferase assay. The extent of NF-B activation was assessed after 6 hours stimulation with IL-1 626 and baseline suppression of the reporter gene was assessed using sterile BHI medium (** p<0.01, *** p<0.001, **** p<0.0001 as determined 627 by one-way ANOVA with Dunnett's multiple comparison test). 628 Figure 6A . GTDB based phylogeny of E. faecalis as determined from the concatenation of 120 universal bacterial-specific marker genes. 649
The source of individual commensal (green), uncharacterised (orange) and pathogenic (red) strains is indicated. The bootstrap values are 650 indicated using a cut-off of >80 or >90%. B. The extent of genome synteny between E. faecalis AHG0090 and a representative pathogenic 651 strain (E. faecalis V583) and commensal (E. faecalis 62) that have closed genome sequences. The red lines for E. faecalis V583 and 62 652 indicated boundaries of the chromosomes and plasmids whereas the red lines for E. faecalis AHG0090 indicate individual contig sequences. 653
